Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Teleflex (TFX) and Axsome Therapeutics (AXSM)
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological
Teleflex Maintains Dividend at $0.34 per Share; Payable on June 14 to Shareholders of Record on May 15
06:53 AM EDT, 05/06/2024 (MT Newswires) -- Teleflex Maintains Dividend at $0.34 per Share; Payable on June 14 to Shareholders of Record on May 15
Press Release: Teleflex Announces Quarterly Dividend
Teleflex Announces Quarterly Dividend WAYNE, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of
Teleflex (TFX) Q1 Earnings Beat Estimates, Margins Rise
Research Alert: CFRA Keeps Hold Opinion On Shares Of Teleflex Incorporated
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target price to $222
Teleflex Is Maintained at Hold by Truist Securities
Teleflex Is Maintained at Hold by Truist Securities
Truist Securities: Maintaining the Teleflex (TFX.US) rating, adjusted from holding to holding rating, and adjusted target price from $240.00 to $219.00.
Truist Securities: Maintaining the Teleflex (TFX.US) rating, adjusted from holding to holding rating, and adjusted target price from $240.00 to $219.00.
Truist Securities Maintains Hold on Teleflex, Lowers Price Target to $219
Truist Securities analyst Richard Newitter maintains Teleflex with a Hold and lowers the price target from $240 to $219.
Teleflex First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Wells Fargo Sticks to Its Hold Rating for Teleflex (TFX)
Teleflex (TFX) Gets a Buy From RBC Capital
RBC Capital Adjusts Price Target on Teleflex to $255 From $265
Teleflex (TFX) has an average rating of hold and price targets ranging from $205 to $285, according to analysts polled by Capital IQ.
Needham Reiterates Hold on Teleflex
Needham analyst Mike Matson reiterates Teleflex (NYSE:TFX) with a Hold.
Teleflex Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 — Needham Reiterates → Hold 02/23/2024 43.41% JMP Securities → $285 Reiterates Market Outperfo
Teleflex Inc (TFX) Q1 2024 Earnings Call Transcript Highlights: Strong Start With Revenue and ...
Earnings Call Summary | Teleflex(TFX.US) Q1 2024 Earnings Conference
The following is a summary of the Teleflex Incorporated (TFX) Q1 2024 Earnings Call Transcript:Financial Performance:Teleflex reported Q1 2024 revenues of $737.8 million, up 3.8% YoY on a GAAP and con
Needham Sticks to Their Hold Rating for Teleflex (TFX)
Wells Fargo Cuts Price Target on Teleflex to $210 From $265
Teleflex (TFX) has an average rating of hold and price targets ranging from $211 to $285, according to analysts polled by Capital IQ. Price: 200.19, Change: -11.35, Percent Change: -5.37
How Is The Market Feeling About Teleflex?
Teleflex's (NYSE:TFX) short percent of float has risen 20.56% since its last report. The company recently reported that it has 888 thousand shares sold short, which is 2.99% of all regular shares that
No Data